Khavinson BioregulatorAlso known as: Eye Extract Bioregulator, Ocular Cytomax

Normoftal

Normoftal is an advanced natural Cytomax bioregulator derived from the retinal and ocular tissues of young animals. It is recognized as a profound biological defense against the degenerative aging of the eye. Deployed aggressively in clinical ophthalmology and elite anti-aging protocols, it aims to forcefully halt the progression of age-related macular degeneration, aggressively mitigate diabetic retinopathy, and systematically reverse the decline of absolute visual acuity.

Reviewed by CalcMyPeptide Editorial Team

·Last updated: April 2026·Evidence: Low

Quick Stats

Half-LifeShort (dipeptide)

Dose Range1-2 capsules/day

Frequency1-2× daily for 10-30 day cycles

Vial SizesN/A (oral)

BioavailabilitySublingual, injection, or oral drops

Year Developed1990s

Scientific Data

Molecular Formula

C11H21N3O5

Molecular Weight

275.30 g/mol

CAS Number

N/A

PubChem ID

N/A

Developer

Vladimir Khavinson, St. Petersburg Institute of Bioregulation

Mechanism of Action

Normoftal (Lys-Glu) is a synthetic dipeptide bioregulator designed to target the retina and ocular tissues. Through the Khavinson gene-regulatory mechanism, it penetrates ocular cells to stimulate division, differentiation, and repair of the retinal epithelium and photoreceptors. In Russian clinical trials, it is used for macular degeneration, diabetic retinopathy, and overall vision preservation.

Source: PMID: 15677927

Background & History

Normoftal is an ocular Cytomax extract targeting retinal and eye tissue.

Research Use Cases

✓Visual health
✓Macular degeneration support
✓Retinal protection

Dosing Protocol

Typical Dose	1-2 capsules/day
Frequency	1-2× daily for 10-30 day cycles
Half-Life	~30 minutes (estimated)

Dosing Protocols

Khavinson Protocol

Dose

10 - 20 mg

Frequency

Daily SubQ for 10 days, 1-2x per year

Note: Retinal bioregulator. Often paired with Visoluten (eye extract) for comprehensive vision support.

Administration

Route

Sublingual tablets or subcutaneous injection

Timing

Morning.

Fasting Required?

No — food timing not critical

Expected Timeline

Day 1-10 (course)

Retinal gene expression restoration initiated.

Who Is It For?

Ocular Health / Retinopathy

Low

Vision bioregulator. Counterpart to the Cytomax Visoluten.

Safety & Considerations

Research peptide. Extensively used in Russian clinical protocols. Excellent safety profile.

Regulatory & Legal Status

FDA Status (US)

Research Only

WADA Status (2026)

Not Listed

Not currently on the WADA 2026 Prohibited List. Policies may change — verify before competition.

Classification

Research Chemical

US Compounding: Not eligible / not available

⚠️ This information is for educational purposes only and may not reflect the most current regulatory updates. Always verify with official FDA, WADA, and jurisdiction-specific sources before use.